Achieve Life Sciences Inc. Insider Trading

ACHV

Last 12 months

Insiders sold 175K and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. The last open-market buy by an executive or director was in Mar 2025.

Net open-market

−175K

0 buys · 1 sale

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

0 / 1

executives and directors

Last open-market buy

Mar 2025

Mar 17, 2025

Get an email when ACHV's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Aug 19	Richard Alistair Stewart Director	SoldNo plan	20,626	$8.49	175K	9.0%	Form 4
Sep 18, 2025	Mark K Oki Chief Financial Officer	SoldNo plan	50,060	$2.92	146K	28%	Form 4
Sep 18, 2025	Richard Alistair Stewart Chief Executive Officer	SoldNo plan	129,501	$2.92	378K	36%	Form 4
Sep 4, 2025	Jerry Wan Principal Accounting Officer	SoldNo plan	14,070	$2.77	39K	30%	Form 4
Sep 4, 2025	Thomas Braxton King Director	SoldNo plan	139,858	$2.77	387K	31%	Form 4
Sep 4, 2025	Cindy Jacobs President & CMO	SoldNo plan	27,629	$2.77	77K	19%	Form 4
Sep 4, 2025	Jaime Xinos Chief Commercial Officer	SoldNo plan	20,854	$2.77	58K	22%	Form 4
Mar 17, 2025	Mark K Oki Chief Financial Officer	Bought	10,000	$2.89	29K	New	Form 4
Mar 17, 2025	Richard Alistair Stewart Chieve Executive Officer	Bought	10,000	$2.86	29K	19%	Form 4

Aug 19No plan
Richard Alistair Stewart
Director · sold 20,626 at $8.49
175K
9.0% of stake
Sep 18, 2025No plan
Mark K Oki
Chief Financial Officer · sold 50,060 at $2.92
146K
28% of stake
Sep 18, 2025No plan
Richard Alistair Stewart
Chief Executive Officer · sold 129,501 at $2.92
378K
36% of stake
Sep 4, 2025No plan
Jerry Wan
Principal Accounting Officer · sold 14,070 at $2.77
39K
30% of stake
Sep 4, 2025No plan
Thomas Braxton King
Director · sold 139,858 at $2.77
387K
31% of stake
Sep 4, 2025No plan
Cindy Jacobs
President & CMO · sold 27,629 at $2.77
77K
19% of stake
Sep 4, 2025No plan
Jaime Xinos
Chief Commercial Officer · sold 20,854 at $2.77
58K
22% of stake
Mar 17, 2025
Mark K Oki
Chief Financial Officer · bought 10,000 at $2.89
29K
New position
Mar 17, 2025
Richard Alistair Stewart
Chieve Executive Officer · bought 10,000 at $2.86
29K
19% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch ACHV, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

In Vitro & In Vivo Diagnostic Substances · Pick stocks to compare with ACHV

CompareIntrinsic value

IMDXInsight Molecular Diagnostics Inc.

$2.65-3.28%25

CDIOCardio Diagnostics Holdings Inc.

$1.65+2.81%30

QDELQuidelOrtho Corporation

$14.35+1.85%0

NTLAIntellia Therapeutics Inc.

$12.31+3.79%33

TKNOAlpha Teknova, Inc.

$7.37+0.41%15

LNTHLantheus Holdings, Inc.

$101.14+0.34%92

CLDXCelldex Therapeutics Inc.

$29.93+0.74%10

IDXXIDEXX Laboratories, Inc.

$698.55+3.94%80

Held by ETFs

ACHV is in 12 US ETFs. The largest of them, with ACHV's weight in each:

Spot a number that looks wrong? Check it in ACHV's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing ACHV

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.